Follow-up over 10 years may show different patterns, and experts predict DCBs will likely be useful in certain populations.
Expert researchers and clinicians from the Leon H. Charney Division of Cardiology at NYU Langone will present practice-changing studies, translational research, and clinical insights at the 2025 ...
NEW HOPE, PA — Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO) announced a new agreement with Japan’s Terumo Corporation (TYO: ...
How Metamaterial Design Could Give Interventional Cardiologists Finer Control in Complex Heart Surgeries Coronary artery disease afflicts 18 million ...